首页|尼麦角林联合高压氧治疗对急性缺血性脑卒中患者神经功能和血清因子的影响

尼麦角林联合高压氧治疗对急性缺血性脑卒中患者神经功能和血清因子的影响

扫码查看
目的 探讨尼麦角林联合高压氧治疗对急性缺血性脑卒中(AIS)患者神经功能、血清因子的影响.方法 选取2023年10月至2024年2月安庆一一六医院收治的94例AIS患者,男性47例,女性47例,年龄(62.01±7.15)岁,年龄范围为50~70岁.采用随机数表法将患者随机分为高压氧组(n=46)和尼麦角林组(n=48).高压氧组患者行高压氧联合常规治疗,尼麦角林组患者在高压氧组患者治疗的基础上口服尼麦角林,持续治疗14 d后,比较两组患者的治疗效果、神经损伤情况[美国国立卫生研究院卒中量表(NIHSS)评分]和生活自理能力(Barthel指数评分)、血管内皮生长因子(VEGF)水平、神经元特异性烯醇化酶(NSE)水平、炎症因子[超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、脂蛋白相关磷脂酶A2(Lp-PLA2)、肿瘤坏死因子α(TNF-α)]水平及不良反应发生率.结果 尼麦角林组患者治疗有效率高于高压氧组,差异有统计学意义(P<0.05).治疗14d后,尼麦角林组Barthel指数评分高于高压氧组,NIHSS评分、VEGF、NSE、hs-CRP、Lp-PLA2、IL-6及TNF-α水平低于高压氧组,差异均有统计学意义(P<0.05).两组患者不良反应发生率比较,差异无统计学意义(P>0.05).结论 尼麦角林联合高压氧治疗AIS的有效率较高,其可促进患者神经功能恢复,提高患者生活自理能力,且安全性较高.
Effects of nicergoline combined with hyperbaric oxygen on neurological function and serum factors in acute ischemic stroke
Objective To investigate the effects of nicergoline combined with hyperbaric oxygen on neurological function and serum factors in acute ischemic stroke(AIS).Methods A total of 94 AIS patients admitted to Anqing 116th Hospital from October 2023 to February 2024 were selected as objects,including 47 males and 47 females,aged(62.01±7.15)years old,ranging from 52 to 70 years old;and they were randomly divided into hyperbaric oxygen group(n=46)and Niergoline group(n=48)by random number table method.Hyperbaric oxygen group was treated with hyperbaric oxygen combined with conventional treatment,and Niergoline group was treated with nicergoline on the basis of hyperbaric oxygen group.After 14 days of treatment,the therapeutic effect,nerve injury[National Institutes of Health Stroke Scale(NIHSS)score],self-care ability(Barthel index score),vascular endothelial growth factor(VEGF)level,neuron-specific enolase(NSE)level,inflammatory factor[hypersensitive C-reactive protein(hs-CRP)],interleukin-6(IL-6),lipoprotein-associated phospholipase A2(Lp-PLA2),tumor necrosis factor α(TNF-α)]and the incidence of adverse reactions were compared between the two groups were compared.Results The treatment effective rate of niergoline group was higher than that of hyperbaric oxygen group,and the difference was statistically significant(P<0.05).After 14 days of treatment,the Barthel index score of the Niergoline group was higher than that of the hyperbaric oxygen group,and the NIHSS score and levels of VEGF,NSE,hs-CRP,Lp-PLA2,IL-6 and TNF-α were lower than those of the hyperbaric oxygen group,with statistical significance(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The effective rate of niergoline combined with hyperbaric oxygen in AIS treatment is high,which can promote the recovery of patients'neurological function,improve patients'self-care ability,and has high safety.

Acute ischemic strokeNicergolineHyperbaric oxygenSerum factorNeurological function

王静、刘学春、张德智、江静如

展开 >

安庆一一六医院神经内科,安徽安庆 246003

合肥市第二人民医院神经内科,安徽 合肥 230012

急性缺血性脑卒中 尼麦角林 高压氧 血清因子 神经功能

2025

创伤与急危重病医学

创伤与急危重病医学

ISSN:
年,卷(期):2025.13(1)